William Blair & Company’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $255K | Sell |
104,211
-7,264
| -7% | -$17.8K | ﹤0.01% | 1321 |
|
|
2025
Q1 | $744K | Sell |
111,475
-4,563
| -4% | -$30.4K | ﹤0.01% | 966 |
|
|
2024
Q4 | $1.46M | Sell |
116,038
-18,931
| -14% | -$238K | ﹤0.01% | 790 |
|
|
2024
Q3 | $2.49M | Sell |
134,969
-7,745
| -5% | -$143K | 0.01% | 651 |
|
|
2024
Q2 | $3.07M | Sell |
142,714
-4,566
| -3% | -$98.3K | 0.01% | 590 |
|
|
2024
Q1 | $3.97M | Buy |
147,280
+401
| +0.3% | +$10.8K | 0.01% | 524 |
|
|
2023
Q4 | $4.4M | Sell |
146,879
-2,910
| -2% | -$87.2K | 0.02% | 485 |
|
|
2023
Q3 | $3.07M | Buy |
+149,789
| New | +$3.07M | 0.01% | 552 |
|
|
2022
Q4 | – | Sell |
-11,431
| Closed | -$182K | – | 1869 |
|
|
2022
Q3 | $182K | Sell |
11,431
-1,300
| -10% | -$20.7K | ﹤0.01% | 1402 |
|
|
2022
Q2 | $175K | Buy |
12,731
+180
| +1% | +$2.47K | ﹤0.01% | 1455 |
|
|
2022
Q1 | $199K | Buy |
12,551
+400
| +3% | +$6.34K | ﹤0.01% | 1516 |
|
|
2021
Q4 | $265K | Sell |
12,151
-100
| -0.8% | -$2.18K | ﹤0.01% | 1467 |
|
|
2021
Q3 | $366K | Sell |
12,251
-350
| -3% | -$10.5K | ﹤0.01% | 1276 |
|
|
2021
Q2 | $558K | Sell |
12,601
-1,905
| -13% | -$84.4K | ﹤0.01% | 1115 |
|
|
2021
Q1 | $644K | Sell |
14,506
-4,060
| -22% | -$180K | ﹤0.01% | 1046 |
|
|
2020
Q4 | $1.02M | Sell |
18,566
-20,438
| -52% | -$1.12M | ﹤0.01% | 844 |
|
|
2020
Q3 | $892K | Buy |
39,004
+221
| +0.6% | +$5.05K | ﹤0.01% | 787 |
|
|
2020
Q2 | $812K | Buy |
38,783
+3,791
| +11% | +$79.4K | ﹤0.01% | 782 |
|
|
2020
Q1 | $488K | Sell |
34,992
-51,965
| -60% | -$725K | ﹤0.01% | 876 |
|
|
2019
Q4 | $1.98M | Buy |
+86,957
| New | +$1.98M | 0.01% | 608 |
|